Skip to main content
. 2021 Sep 9;9(4):1707–1715. doi: 10.1002/iid3.526

Table 1.

Demographic and clinical characteristics of study subjects

Healthy

(16)

Moderate/severe

(30)

Critical

(14)

p
Age (years) 38.19 (8.81) 58.33 (18.49) 52.64 (17.83)
Gender
Female 5 14 6
Male 11 16 8
Temperature 36.56 (0.108) 37.41 (1.007) 37.41 (0.401) <.0001
Cough 0 (0%) 23 (76%) 12 (85%) <.0001
Smoking 1 (0.06%) 4 (0.13%) 0 (0%) .3555
chronic underlying disease 0 12 (40%) 10 (71%) .0006
LDH (U/L) 251.9 (80.86) 556.4 (268.5) 1863 (2709) <.0001
C‐reactive protein (mg/dl) 1.746 (1.563) 81.97 (68.83) 191.3 (116.6) <.0001
ESR (mm/h) 10.71 (3.989) 61.21 (45.62) 69.58 (32.49) <.0001
Ferritin (ng/ml) 102.9 (51.98) 689.6 (731.9) 1129 (1071) .0002
BUN (mg/dl) 15.00 (3.486) 21.35 (19.54) 39.54(27.20) .0005
Creatinine (mg/dl) 0.8143 (0.1076) 1.993 (2.764) 2.106 (2.114) .0673
AST (IU/L) 21.36 (3.875) 51.57 (65.96) 120.3 (201.5) .0100
ALT (IU/L) 18.00 (6.493) 39.33 (27.49) 180.5 (333.9) .0171
WBC 7490 (1798) 8243 (3631) 9407 (3693) .2949
Lymphocytes (% in differential) 32.19 (4.324) 23.43 (12.01) 12.29 (5.121) <.0001
Lymphocytes (absolute number) 2384 (534.7) 1825 (1130) 1069 (409.9) <.0001
Neutrophil (% in differential) 67.20 (10.11) 70.07 (11.92) 84.21 (8.059) .0002
Neutrophil (absolute number) 5059 (1530) 5897 (3048) 8036 (3595) .0234
PLT 269,267 (103,425) 267,467 (137,550) 211,429 (132,324) .3101
NLR 2.159 (0.5858) 3.98 (2.308) 8.571 (4.927) <.0001
PLR 114.2 (39.30) 184.4 (108.1) 207.2 (125.9) .0308
Hb (mg/dl) 14.58 (1.546) 11.06 (1.284) 10.45 (1.599) <.0001

Abbreviations: ALT, alanine aminotransferease; AST, aspartate aminotransferase; BUN, blood urea nitrogen; ESR, erythrocyte sedimentation rate; LDH, lactate dehydrogenase; NLR, neutrophil‐lymphocyte ratio; PLR, platelet‐lymphocyte ratio; PLT, platelet; WBC, white blood cell.